Document is current

Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001701corr1

Published Online: 2021-10-13

Published Print: 2021-10

Update policy: https://doi.org/10.1136/crossmarkpolicy